Kemwell Biopharma
Biotechnology Research • 
Nelamangala, Karnataka, India • 501-1000 Employees
Company overview
| Headquarters | 34th KM Tumkur Road, T-Begur, Nelamangala Taluk, Bangalore, 562123, IN |
| Phone number | +918026982400 |
| Websites | |
| SIC | 283 |
| Keywords | CMO, Quality Control, Biologics, Process Development, Cdmo, Monoclonal Antibodies, Analytical Development, Contract Analytical Services, Contract Biopharmaceutical Development, Contract Biopharmaceutical Manufacturing, Bispecific Antibody, Drug Product Manufacturing, Fill-Finish, Fusion Protein, Lyophilised Injectable, Liquid Injectable |
| Founded | 1980 |
| Employees | 501-1000 |
| Socials |
Key Contacts at Kemwell Biopharma
Ripple Mehta
Director - Bd And Strategic Alliance
Anindita Das
Senior Director
Diksha Gupta
Director Of Business Development
Neetu Manglani
Head Upstream - Associate Director Process Development & Tech Transfer
Sudarshan Reddy
Director - Ds Manufacturing
Manan Dave
Associate Director Head - Validation & Engineering Qa
Santosh Jadhav
Director & Head Qc
Sr Chandak Kemwell
Finance Director
Sankarareddy Soma
Director
Kemwell Biopharma Email Formats
Kemwell Biopharma uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@kemwellpharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@kemwellpharma.com | 100% |
About Kemwell Biopharma
Kemwell is a contract biologics development and CMO company providing services to global biopharmaceutical organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing. 15,000 sq. m. Kemwell facility consists of a cGMP drug substance manufacturing area with over 4500L bioreactor capacity, sterile fill and finish areas for cGMP drug product manufacturing and process development laboratories to support production of protein therapeutics from mammalian-cell culture – monoclonal antibodies, bi-specific antibodies, fusion proteins, etc. Kemwell is capable of supporting novel, bio-better and biosimilar programs’ preclinical development, clinical development, cGMP clinical manufacturing and cGMP commercial manufacturing. Kemwell, having established in 1980, had long term associations with pharma majors such as Bayer, GlaxoSmithKline, Merck KGaA, Novartis, Pfizer and others for small molecule contract mfg. and R&D. In 2016, Kemwell divested its small-molecule division to focus on biologics, leveraging its vast and rich experience. Kemwell is now a 100% biologics CDMO.
Kemwell Biopharma revenue & valuation
| Annual revenue | $32,000,000 |
| Revenue per employee | $60,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $102,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Kemwell Biopharma has 177 employees across 12 departments.
Departments
Number of employees
Funding Data
Kemwell Biopharma has never raised funding before.
Kemwell Biopharma Tech Stack
Discover the technologies and tools that power Kemwell Biopharma's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Caching
CDN
JavaScript libraries
CDN
SEO
JavaScript libraries
Miscellaneous
Programming languages
WordPress plugins
Blogs
Analytics
Australia
Italy
Germany
United Kingdom
Canada
Czechia
Frequently asked questions
4.8
40,000 users
